Duncker Streett & Co. Inc. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 32.2% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 2,048 shares of the healthcare conglomerate’s stock after selling 974 shares during the period. Duncker Streett & Co. Inc.’s holdings in UnitedHealth Group were worth $380,000 as of its most recent filing with the SEC.

Other hedge funds also recently bought and sold shares of the company. Jackson Grant Investment Advisers Inc. boosted its stake in UnitedHealth Group by 0.4% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock worth $180,000 after buying an additional 4 shares during the last quarter. Adirondack Trust Co. boosted its stake in UnitedHealth Group by 0.5% in the first quarter. Adirondack Trust Co. now owns 990 shares of the healthcare conglomerate’s stock worth $162,000 after buying an additional 5 shares during the last quarter. RB Capital Management LLC boosted its stake in UnitedHealth Group by 0.4% in the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after buying an additional 7 shares during the last quarter. Altfest L J & Co. Inc. boosted its stake in UnitedHealth Group by 0.3% in the second quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after buying an additional 10 shares during the last quarter. Finally, Parkside Financial Bank & Trust boosted its stake in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the last quarter. 86.21% of the stock is owned by institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE UNH) traded down 0.61% during midday trading on Friday, reaching $191.53. The company’s stock had a trading volume of 1,459,494 shares. UnitedHealth Group Incorporated has a 12 month low of $132.39 and a 12 month high of $196.04. The stock has a market capitalization of $185.18 billion, a PE ratio of 23.01 and a beta of 0.64. The stock’s 50 day moving average is $190.34 and its 200 day moving average is $175.66.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm’s revenue was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.96 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.56%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

ILLEGAL ACTIVITY NOTICE: This story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this story can be read at https://www.thecerbatgem.com/2017/08/18/duncker-streett-co-inc-sells-974-shares-of-unitedhealth-group-incorporated-unh.html.

A number of analysts have weighed in on the company. UBS AG reaffirmed a “buy” rating and set a $194.00 price objective (up from $193.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Morgan Stanley increased their target price on UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Thursday. Jefferies Group LLC reissued a “buy” rating and set a $215.00 target price on shares of UnitedHealth Group in a research note on Friday. Cantor Fitzgerald reissued an “overweight” rating and set a $205.00 target price (up from $200.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Finally, Sanford C. Bernstein reissued an “outperform” rating and set a $190.00 target price on shares of UnitedHealth Group in a research note on Monday, July 10th. One analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $203.41.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the transaction, the director now owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the transaction, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders sold 15,540 shares of company stock worth $2,873,320 in the last ninety days. 0.89% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.